Point-of-care test for the detection of K2 and other synthetic cannabinoids in patient samples. Enables identification of emerging synthetic drug use in clinical settings.
Manufactured by
Shanghai, China
The two Production Plants of Shanghai Chemtron Biotech Co., Ltd. are located in the International Medical Park, Zhangjiang Development Zone, Pudong New District and Xiasha Town, Pudong New District in Shanghai. Chemtron was founded in January 2001, a high-tech enterprise in Shanghai, a vice president unit of the medical laboratory industry branch of the health industry management association, and a patent demonstration enterprise in Shanghai. Chemtron specializes in R D, production, sales and services of in-vitro rapid detection of diagnostic reagents. Chemtron has Production Plants over 17000 square meters with facilities for advanced R D, production, quality inspection equipment and instruments of in-vitro diagnostic reagent with an annual production capacity of 320 million. In San Diego, California, the United States, Chemtron (U.S.) company has established a sole-owned product development center and production plant. At present, there are 194 employees, 110 with Bachelor s degree or above including 3 Doctors, 10 Masters, accounting for 52.9% of the total employees of the company. In 2004, Chemtron passed the international certification of ISO13485 authoritative quality system; in March 2005, Chemtron passed the GMP certification of the State Food and drug administration; in 2009, it was listed in the biomedical industrialization project of Shanghai government; Chemtron s main products obtained the CE certificate in EU; 12 drug testing products series have obtained the FDA certification of the United States. Chemtron has established a first-class “Chemtron R D technology center” in the United States and China. Based on the platform of monoclonal antibody technology and laboratory medicine technology, Chemtron has speeded up the R D and marketing of its products. Chemtron has continuously developed and launched fast, sensitive, specific and accurate in-vitro diagnostic products. Chemtron now has a series of in-vitro diagnostic reagents under the national registered trademark Chemtrue , with a total of 6 series of products of more than 40 varieties: such as drug detection; tumor detection; infectious disease detection; cardiovascular disease detection; hormone detection and POCT rapid quantitative intelligent instrument with supporting CRP, HCG, MAU, cTnI, myocardial infarction three-in-one, PCT, D2 polymer and other products. Chemtron has always adhered to the business philosophy of quality, reputation, service and sincerity and the quality policy of perfect quality, standardized management, innovation and sincere service . Chemtron s products are sold to over 70 countries and regions around the world, such as the United States, Russia, Europe, South America, Middle East, East Asia, etc. Chemtron is willing to work together with you to relieve human suffering!
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
HANGZHOU BIOEAST BIOTECH CO.,LTD
China · 2 relevant products
Hangzhou Elit Biotech Co.,Ltd.
China · 5 relevant products
VEDALAB SAS
France · 2 relevant products
ASC LLC
United States · 5 relevant products
Assure Tech. (Hangzhou) Co., Ltd.
China · 3 relevant products
InTec PRODUCTS, INC.
China · 1 relevant product
NTBIO Diagnostics Inc.
Canada · 5 relevant products
AEHEALTH Limited
China · 1 relevant product
Euromed Biotech GmbH
Germany · 1 relevant product
Nantong Egens Biotechnology Co., Ltd.
China · 1 relevant product
43 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 109 closest product alternatives
HANGZHOU BIOEAST BIOTECH CO.,LTD · China
Rapid diagnostic test uncut sheet for synthetic cannabinoid (K2) detection in hair samples using colloidal gold technology. Dimensions of 6cm×30cm with sensitivity of 20 ng/mL.
Hangzhou Elit Biotech Co.,Ltd. · China
A rapid diagnostic test for the detection of K2 (synthetic cannabinoids) in biological samples. This test provides quick screening results for the presence of synthetic marijuana compounds.
HANGZHOU BIOEAST BIOTECH CO.,LTD · China
Hair-based diagnostic test sheet for detecting synthetic cannabinoids (K2) using fluorescence immunochromatography method. Dimensions are 6cm×30cm with a detection sensitivity of 2ng/ml.
VEDALAB SAS · France
Immunochromatographic rapid tests for qualitative detection of drugs of abuse including cannabinoids, cocaine, opiates, and amphetamines in whole blood, plasma, or serum samples. CE-marked in vitro diagnostic tests designed for home use and professional screening applications with single-drug detection per test format.
ASC LLC · United States
Synthetic cannabinoid (K2/Spice) screening test with 50 ng/mL cutoff for rapid detection. Suitable for occupational and clinical substance abuse monitoring applications.
VEDALAB SAS · France
Immunochromatographic rapid test for qualitative detection of cannabinoid metabolites in biological samples. Designed for professional use in drug screening programs.
Assure Tech. (Hangzhou) Co., Ltd. · China
Multi-analyte rapid test for simultaneous detection of multiple drugs of abuse in urine samples. Available in various panel configurations for comprehensive substance screening.
InTec PRODUCTS, INC. · China
Rapid immunochromatographic assay for qualitative detection of drugs of abuse in human samples. Point-of-care screening test for substance abuse detection.
NTBIO Diagnostics Inc. · Canada
Comprehensive panel format rapid test for simultaneous detection of multiple drugs of abuse. Provides qualitative results for emergency screening and preliminary analysis.
AEHEALTH Limited · China
In vitro diagnostic kit for detection of drugs of abuse in patient specimens. Used for toxicology screening in clinical and occupational settings.
Euromed Biotech GmbH · Germany
A self-testing diagnostic kit for the detection of drugs of abuse. This point-of-care test is designed for in vitro diagnostics and allows for rapid screening of substance use.
Nantong Egens Biotechnology Co., Ltd. · China
Rapid and laboratory-based test kits for detection of controlled substances in biological samples. Designed for workplace screening, clinical diagnosis, and forensic applications.
97 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products